The UK Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-2030. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. To get a detailed report, contact us at - info@insights10.com
UK Electronic Health Records Market Analysis Sample ReportInsights10
The UK electronic health record market size was valued at $736 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $862 Mn in 2030. This growth can be attributed to Technological advancements in healthcare offering a promising future for enhancing healthcare delivery through electronic health records. The market is segmented by product type, application type, and end user. To get a detailed report, contact us at - info@insights10.
UK ePharmacy Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Patient Recruitment Services Market Analysis Sample ReportInsights10
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Report Overview
The UK Physiotherapy Service market size stood at USD 4.64 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The physiotherapy market is poised for a surge in growth in 2019. Traditionally a highly fragmented market, the sector is ripe for consolidation via transformational M&A and private equity investment. From urgent in-person care to innovative technology solutions for both public and private business, the market includes a wide-range of services and demand is leading to an upsurge in investment in UK businesses. Demand for physical therapy is on the rise, driven by the prolonged effects of the pandemic.
Market Growth Drivers
Physiotherapy-led services are increasing in demand with an aging population set to expand by 4m over the next 10 years. This population will drive higher incident rates (30% of the UKs over 65s experience a fall at least once a year costing the National Health Service (NHS) around £2.3bn a year) and outsourced physiotherapy services could save the NHS an estimated £275m a year.
Clinical commissioning groups currently outsource almost a third of their physiotherapy services and the opportunities for private providers are growing. A recent report by the Centre for Health and the Public Interest has uncovered the amount spent in the private sector by local commissioning bodies and NHS trusts has increased by 50. Increased focus on wellness and preventative treatments from the public will also support long-term revenue growth.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Norway Medical and Diagnostic Laboratory Service Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Norway Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Korea Telemedicine Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the South Korea Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
New Zealand Dental Care Market Analysis Sample reportInsights10
The New Zealand dental care services market is at around $1.31 Bn in 2022 and is projected to reach $1.88 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period (2022-2030). Most dental services being rendered are funded by the Universal Health Coverage (UHC) endeavour of the government and primarily addresses vulnerable age groups and native communities propelled by the increased coverage by private insurance. To get a detailed report, contact us at - info@insights10.com
UK Electronic Health Records Market Analysis Sample ReportInsights10
The UK electronic health record market size was valued at $736 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $862 Mn in 2030. This growth can be attributed to Technological advancements in healthcare offering a promising future for enhancing healthcare delivery through electronic health records. The market is segmented by product type, application type, and end user. To get a detailed report, contact us at - info@insights10.
UK ePharmacy Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Patient Recruitment Services Market Analysis Sample ReportInsights10
The Global clinical trial patient recruitment services market is projected to grow from $ 0.84 Mn in 2022 to $1.56 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-30. The Global clinical trial patient recruitment services market is a rapidly growing market that provides services to support the recruitment of patients for clinical trials. To get a detailed report, contact us at - info@insights10.com
Hong Kong Pharmaceutical Market AnalysisInsights10
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Report Overview
The UK Physiotherapy Service market size stood at USD 4.64 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
The physiotherapy market is poised for a surge in growth in 2019. Traditionally a highly fragmented market, the sector is ripe for consolidation via transformational M&A and private equity investment. From urgent in-person care to innovative technology solutions for both public and private business, the market includes a wide-range of services and demand is leading to an upsurge in investment in UK businesses. Demand for physical therapy is on the rise, driven by the prolonged effects of the pandemic.
Market Growth Drivers
Physiotherapy-led services are increasing in demand with an aging population set to expand by 4m over the next 10 years. This population will drive higher incident rates (30% of the UKs over 65s experience a fall at least once a year costing the National Health Service (NHS) around £2.3bn a year) and outsourced physiotherapy services could save the NHS an estimated £275m a year.
Clinical commissioning groups currently outsource almost a third of their physiotherapy services and the opportunities for private providers are growing. A recent report by the Centre for Health and the Public Interest has uncovered the amount spent in the private sector by local commissioning bodies and NHS trusts has increased by 50. Increased focus on wellness and preventative treatments from the public will also support long-term revenue growth.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Norway Medical and Diagnostic Laboratory Service Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Norway Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
South Korea Telemedicine Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the South Korea Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
New Zealand Dental Care Market Analysis Sample reportInsights10
The New Zealand dental care services market is at around $1.31 Bn in 2022 and is projected to reach $1.88 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period (2022-2030). Most dental services being rendered are funded by the Universal Health Coverage (UHC) endeavour of the government and primarily addresses vulnerable age groups and native communities propelled by the increased coverage by private insurance. To get a detailed report, contact us at - info@insights10.com
Portugal Medical Devices Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Portugal Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Singapore Dental Care Market Analysis Sample ReportInsights10
Singapore's dental care services market size is at around $43.06 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. This report by Inisghts10 is segmented by treatment type, age group, and by clinical setup, and demography. To get a detailed report, contact us at - info@insights10.com
Vietnam Home Healthcare Market Analysis Sample ReportInsights10
The Vietnam home healthcare market was valued at $1.813 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $3.34 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the ageing population. The market is segmented by components and services. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
Kuwait Dental Care Market Analysis Sample ReportInsights10
The Kuwait dental care market size is at around $143.52 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period (2022-2030). With an oil-based economy, Kuwait attracts migrants from all over the world, and with the deficit in public health services, private providers in dental care are proliferating. To get a detailed report, contact us at - info@insights10.com
Australia Home Healthcare Market Analysis Sample ReportInsights10
Australia's home healthcare market is projected to grow from $4.35 Bn in 2022 to $8.94 Bn in 2030 with a CAGR of 9.43% for the year 2022-2030. The market has witnessed significant growth post-pandemic. The market is segmented by product, service, software, and by region. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
Saudi Arabia Dialysis Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Saudi Arabia Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada Clinical Diagnostics Market Sample Report 2022 to 2030Insights10
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30.
UK Physiotherapy Market Analysis Report 2022 to 2030Insights10
The UK physiotherapy market size was valued at $1.38 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $1.87 Bn in 2030. The UK physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the UK physiotherapy market are Machine Medicine, PneumaCare, Qured, Action First Physiotherapy Ltd, and others.
Egypt's connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application.
To get a detailed report, contact us at - info@insights10.com
Africa Dialysis Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Africa Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Africa Dialysis Market Report 2022 to 2030Insights10
This report presents a strategic analysis of the Africa Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook.
Egypt Home Healthcare Market Analysis Sample ReportInsights10
The Egypt Home Healthcare Market is witnessing lucrative growth opportunities as the demand for high-quality home healthcare services increase in Egypt. The rising geriatric population and associated lifestyle diseases in Egypt are primarily responsible for the growth of the market. Alrazy Group and Manzil Home Health Services are some of the major players in the Egypt home healthcare market. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the UAE nutrition and supplements market will reach a value of $3.94 Bn from $1.91 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Vitabiotics Ltd, Bayer Middle East, and Forever Living Products. To get a detailed report, contact us at - info@insights10.com
Global Dental Care Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Global Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook.
To get a detailed report, contact us at - info@insights10.com
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
More Related Content
Similar to UK Coronary Stents Market Analysis Sample Report
Portugal Medical Devices Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Portugal Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
The China Antiepileptic Drug market size stood at around USD XX billion in 2019 and is projected to reach USD 1.16 billion by 2028, exhibiting a CAGR of XX% during the forecast period.
The prevalence of epilepsy in China is 7%, and the prevalence of active epilepsy is 4.6%. In addition, there is a large gap in the treatment of epilepsy, which is about 63%. Based on this, it is estimated that the current epilepsy number of patients is more than 9 million, of which more than 6.4 million are patients with active epilepsy.
Market Drivers
Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic drugs market. Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market. Active government support and Investments are expediting the market growth. The R&D is now focused on the development of target specific drugs.
Visit https://insights10.com/ for more healthcare industry insights.
Connect with us @ info@insights10.com
Singapore Dental Care Market Analysis Sample ReportInsights10
Singapore's dental care services market size is at around $43.06 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. This report by Inisghts10 is segmented by treatment type, age group, and by clinical setup, and demography. To get a detailed report, contact us at - info@insights10.com
Vietnam Home Healthcare Market Analysis Sample ReportInsights10
The Vietnam home healthcare market was valued at $1.813 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $3.34 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the ageing population. The market is segmented by components and services. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Global Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. To get a detailed report, contact us at - info@insights10.com
Kuwait Dental Care Market Analysis Sample ReportInsights10
The Kuwait dental care market size is at around $143.52 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period (2022-2030). With an oil-based economy, Kuwait attracts migrants from all over the world, and with the deficit in public health services, private providers in dental care are proliferating. To get a detailed report, contact us at - info@insights10.com
Australia Home Healthcare Market Analysis Sample ReportInsights10
Australia's home healthcare market is projected to grow from $4.35 Bn in 2022 to $8.94 Bn in 2030 with a CAGR of 9.43% for the year 2022-2030. The market has witnessed significant growth post-pandemic. The market is segmented by product, service, software, and by region. To get a detailed report, contact us at - info@insights10.com
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Global Health Economics and Outcomes Research (HEOR) Services Market Analysis...Insights10
The Global Health Economics and Outcomes Research (HEOR) Services Market is projected to grow from $1.5 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-2030. The market under study is anticipated to be dominated by North America. To get a detailed report, contact us at - info@insights10.com
Saudi Arabia Dialysis Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Saudi Arabia Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Global Clinical Trial Support Services Market AnalysisInsights10
This report presents a strategic analysis of the Global Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Canada Clinical Diagnostics Market Sample Report 2022 to 2030Insights10
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30.
UK Physiotherapy Market Analysis Report 2022 to 2030Insights10
The UK physiotherapy market size was valued at $1.38 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $1.87 Bn in 2030. The UK physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions as well as an aging population. The market is segmented by Product Type, Application Type, and End User. The major players in the UK physiotherapy market are Machine Medicine, PneumaCare, Qured, Action First Physiotherapy Ltd, and others.
Egypt's connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application.
To get a detailed report, contact us at - info@insights10.com
Africa Dialysis Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Africa Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
Africa Dialysis Market Report 2022 to 2030Insights10
This report presents a strategic analysis of the Africa Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook.
Egypt Home Healthcare Market Analysis Sample ReportInsights10
The Egypt Home Healthcare Market is witnessing lucrative growth opportunities as the demand for high-quality home healthcare services increase in Egypt. The rising geriatric population and associated lifestyle diseases in Egypt are primarily responsible for the growth of the market. Alrazy Group and Manzil Home Health Services are some of the major players in the Egypt home healthcare market. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the UAE nutrition and supplements market will reach a value of $3.94 Bn from $1.91 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Vitabiotics Ltd, Bayer Middle East, and Forever Living Products. To get a detailed report, contact us at - info@insights10.com
Global Dental Care Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Global Dental Care Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook.
To get a detailed report, contact us at - info@insights10.com
Similar to UK Coronary Stents Market Analysis Sample Report (20)
INDIA MEDICAL DEVICE REGULATORY LANDSCAPEInsights10
The Indian medical device regulatory landscape is constantly evolving. In recent years, the government has implemented several new regulations to improve the safety and quality of medical devices. This has created new challenges and opportunities for medical device manufacturers and importers. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3T4fMvE
Promising New Cancer Drugs Jan 2024 by Insights10Insights10
Medtech Monday: Bullish Bets on Breakthroughs - Examining Cutting-Edge Trials and Investment Opportunities Attention all healthcare and biotech investors! Buckle up for a deep dive into the hottest clinical trials poised to shape the future of medicine in 2024 and beyond. To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/3uGcvZW
Patient - First Health With Generative AIInsights10
Patient-First Health With Generative AI Learn about the groundbreaking potential of #GenerativeAI in patient engagement, including its three broad categories of use cases. Understand why this innovation is poised to revolutionize patient interaction with their health and the crucial steps stakeholders must take to bring it to fruition. Don't miss this essential read by Insights10 for anyone passionate about the intersection of AI and healthcare! To get a detailed report, contact us at - info@insights10.com, visit - https://bit.ly/42OOgWa
Vietnam In-Vitro Fertilization (IVF) Service Market AnalysisInsights10
This report presents a strategic analysis of Vietnam In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Turkey nutrition and supplements market will reach a value of $6.08 Mn from $3.05 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The nutritional supplements market in Turkey is primarily dominated by local players such as Form Labs, Hülya Şahin, and Solgar. To get a detailed report, contact us at - info@insights10.com
Spain Artificial Intelligence (AI) in Healthcare Market AnalysisInsights10
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED. To get a detailed report, contact us at - info@insights10.com
The Kenya home healthcare market was valued at $XX Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of XX% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by indication and product. To get a detailed report, contact us at - info@insights10.com
Japan Nutritional Supplements Market Analysis.pdfInsights10
By 2030, it is anticipated that the Japan Nutrition and Supplements market will reach a value of $47.25 Bn from $23.71 Bn in 2022, growing at a CAGR of 9% during 2022-30. The market is primarily dominated by local players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto.To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Australian dermatology drugs market will reach a value of $516 Mn from $204 Mn in 2022, growing at a CAGR of 12.3% during 2022-2030. The market is primarily dominated by local players such as Faulding, Bioscience International, Aspen Pharmacare, and Alpha Pharm. The market is driven by an aging population, disparities in universal health coverage, and the launch of new and innovative drugs. To get a detailed report, contact us at - info@insights10.com
India 3D Printing Medical Devices Market AnalysisInsights10
India's 3D printing medical devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. To get a detailed report, contact us at - info@insights10.com
Australia Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the Australian nutrition and supplements market will reach a value of $9.81 Bn from $4.58 Bn in 2022, growing at a CAGR of 10% during 2022-30. The market is primarily dominated by local players such as Blackmores, BioMedicals, Nutralife, and Life-Space. To get a detailed report, contact us at - info@insights10.com
Australia's healthcare diagnostic market is valued at $xx Bn in 2022 and would likely grow at a CAGR of 1.5% during 2022-2030. The Australia healthcare diagnostic market is segmented by product, end-user, and test type. The factors affecting its growth are prevalent chronic diseases, the rising geriatric population, insurance and reimbursement, and regulating bodies. To get a detailed report, contact us at - info@insights10.com
Mexico's connected healthcare market is projected to grow from $995.4 Mn in 2022 to $7469.23 Mn by 2030, registering a CAGR of 28.65% during the forecast period of 2022-30. The main factors driving the growth would be increasing technological adoption, the aging population, the rising prevalence of chronic diseases, and government support. To get a detailed report, contact us at - info@insights10.com
South Africa Nutritional Supplements Market AnalysisInsights10
By 2030, it is anticipated that the South Africa Nutrition and Supplements market will reach a value of $xx Bn from $2.48 Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. To get a detailed report, contact us at - info@insights10.com
Bulgaria Over The Counter (OTC) Pharmaceuticals Market AnalysisInsights10
Bulgaria's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 6.52% from 2022 to 2030 and will reach $227.9 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com
By 2030, it is anticipated that the Japan Radiotherapy Market will reach a value of $711 Mn from $430 Mn in 2022, growing at a CAGR of 6.5% during 2022-30. The Radiotherapy Therapeutics Market in Japan is dominated by a few domestic players such as Hitachi, Mitsubishi Electric Corporation, and IHI Corporation. The radiotherapy market in Japan is segmented into different types, technologies, procedures, applications, and end-users.
To get a detailed report, contact us at - info@insights10.com
Generative AI Startup Scenario in India 2023Insights10
Let's see how Generative AI is revolutionizing Indian Healthcare. Imagine AI generating personalized treatment plans, predicting disease outbreaks, or even designing life-saving drugs. This isn't sci-fi, it's the thriving reality of India's Generative AI healthcare startups in 2023.
Startups like Tricuss, Niramai, PharmEasy, Qure.ai, and HealthifyMe are harnessing the power of generative models to tackle critical healthcare challenges.
Global Breast Cancer Therapeutics Market ArticleInsights10
With an increase in breast cancer cases worldwide and rising investments in the research and development projects for breast cancer treatment, the Global breast cancer therapeutics market is expected to grow from $18.2 Bn in 2022 to $48.04 Bn in 2030 with a CAGR of 12.9% for the year 2022-2030. The market is segmented by therapy, by cancer type, and by distribution channel. To get a detailed report, contact us at - info@insights10.com
Thailand Oral Care Market Analysis Sample ReportInsights10
Thailand's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 5.36% from 2022 to 2030 and will reach $208.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com
This report presents a strategic analysis of the Turkey Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Ear Solutions (ESPL)
Binaural hearing using two hearing aids instead of one offers numerous advantages, including improved sound localization, enhanced sound quality, better speech understanding in noise, reduced listening effort, and greater overall satisfaction. By leveraging the brain’s natural ability to process sound from both ears, binaural hearing aids provide a more balanced, clear, and comfortable hearing experience. If you or a loved one is considering hearing aids, consult with a hearing care professional at Ear Solutions hearing aid clinic in Mumbai to explore the benefits of binaural hearing and determine the best solution for your hearing needs. Embracing binaural hearing can lead to a richer, more engaging auditory experience and significantly improve your quality of life.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
1. UK Coronary
Stents Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)
2. This report presents a strategic analysis of the UK Coronary Stents
Market Analysis and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, types of clinical diagnostics, point-of-care testing,
main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the UK Coronary
Stents Market Analysis, and offers unmatched value, accuracy, and
expert insights
3. 3
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
4. 4
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
1. Coronary Stents Overview 12-25
1.1. Overview
1.2. UK Overview
1.3. Economic Overview: UK
1.4. Coronary Stents in UK
1.5. Medical Devices Market in UK
1.6. Healthcare Scenario in UK
1.7. Health Insurance Coverage: UK
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-33
2.1 Market size and forecasts (Excel and Methodology)
5. 5
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. Type
2.2.2. Mode of Delivery
2.2.3. Materials
2.2.4. End-User
3. Market Dynamics 34-38
3.1. Market Growth Drivers
3.1.1. UK Coronary Stents Market Driver 1
3.1.2. UK Coronary Stents Market Driver 2
3.1.3. UK Coronary Stents Market Driver 3
3.2. Market Restraints
6. 6
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
3.2.1. UK Coronary Stents Market Restraint 1
3.2.2. UK Coronary Stents Market Restraint 2
3.2.3. UK Coronary Stents Market Restraint 3
4. Competitive Landscape 39-49
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Abbott Laboratories
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
7. 7
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.2. Boston Scientific Corporation
4.2.2.2. Overview
4.2.2.2. Product Applications & Services
4.2.2.3. Recent Developments
4.2.2.4. Partnerships Ecosystem
4.2.2.5. Financials (Based on Availability)
4.2.3. Medtronic
4.2.3.1. Overview
4.2.3.2. Product Applications & Services
4.2.3.3. Recent Developments
4.2.3.4. Partnerships Ecosystem
4.2.3.5. Financials (Based on Availability)
8. 8
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.4. Johnson & Johnson
4.2.4.2. Overview
4.2.4.2. Product Applications & Services
4.2.4.3. Recent Developments
4.2.4.4. Partnerships Ecosystem
4.2.4.5. Financials (Based on Availability)
4.2.5. Terumo Corporation
4.2.5.1. Overview
4.2.5.2. Product Applications & Services
4.2.5.3. Recent Developments
4.2.5.4. Partnerships Ecosystem
4.2.5.5. Financials (Based on Availability)
9. 9
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.6. B. Braun Melsungen
4.2.6.1. Overview
4.2.6.2. Product Applications & Services
4.2.6.3. Recent Developments
4.2.6.4. Partnerships Ecosystem
4.2.6.5. Financials (Based on Availability)
4.2.7. C. R. Bard
4.2.7.1. Overview
4.2.7.2. Product Applications & Services
4.2.7.3. Recent Developments
4.2.7.4. Partnerships Ecosystem
4.2.7.5. Financials (Based on Availability)
10. 10
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.8. Cook Medical
4.2.8.1. Overview
4.2.8.2. Product Applications & Services
4.2.8.3. Recent Developments
4.2.8.4. Partnerships Ecosystem
4.2.8.5. Financials (Based on Availability)
4.2.9. MicroPort Scientific Corporation
4.2.9.1. Overview
4.2.9.2. Product Applications & Services
4.2.9.3. Recent Developments
4.2.9.4. Partnerships Ecosystem
4.2.9.5. Financials (Based on Availability)
11. 11
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
Table of Content
CONTENT PG. NO.
4.2.10. Biosensors International Group
4.2.10.2. Overview
4.2.10.2. Product Applications & Services
4.2.10.3. Recent Developments
4.2.10.4. Partnerships Ecosystem
4.2.10.5. Financials (Based on Availability)
5. Reimbursement Scenario 50-57
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope 58-63
13. 13
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.1 Statistics at a Glance: The Scenario of Coronary Stents in the World
Scope of Coronary Stents ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
15.5%
Coronary artery
disease accounts for
15.5% deaths
globally
50%
Of coronary artery blockage,
patients require coronary
stents
80%
Coronary stents are used in
Percutaneous Coronary
Intervention
35
Coronary artery
disease accounts
for one-thirds of
deaths above 35
years of age
85%
Of the Drug Eluting Stents
(DES) are used worldwide
14. 14
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.1 Statistics at a Glance: The Scenario of Coronary Stents in the World
(continued)
North America
~ Market Size of
$27.2 Bn
Europe
~Revenue to reach
$7.6 Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$0.6Bn
Egypt Market
~$118Mn Market
Illustrative
15. 15
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.2 UK Overview
67.3 Mn
Is the population of
UK, in 2021
40
Is the median age
in UK, in 2021
31.3 Mn
Is the Gross
Domestic Product
(GDP) in UK in 2021
$4,545
per capita was the
amount of national
health expenditures in
2021
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
16. 16
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.3 Economic Overview: UK
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of UK, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of UK, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
49%
Female
51%
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
17. 17
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.4 Statistics at a Glance: The Scenario of Coronary Stents in UK
Scope of Coronary Stents
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In this section you will get an
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in UK
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
25,000
People die form
coronary artery
disease in UK
40%
Of coronary artery
blockage, patients require
coronary stents in UK
70%
Coronary stents are used in
Percutaneous Coronary
Intervention in UK
75
Coronary artery
disease
accounts for
deaths above 75
years of age in
UK
18. 18
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.5 Medical Devices in UK
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
UK Medical Devices Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Medical Devices market in UK, which includes the market size, current trends and
other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
19. 19
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.6 Healthcare Scenario in UK
Cancer Drug Development Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research
to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative
20. 20
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.6 Healthcare Scenario: Heart Disease Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative
21. 21
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.7 Health Insurance Coverage: UK
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative
22. 22
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.8 Budget of UK Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
Medicaid $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
Medicaid 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
23. 23
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative
24. 24
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Oracle acquisition of
Cerner
Acquisition $28.3 Bn June, 2022
▪ Oracle’s acquisition of Cerner is big tech’s latest foray into the
healthcare system, promising better outcomes
▪ Oracle acquire Cerner through an all-cash tender offer for $95.00
per share, or approximately $28.3 Bn in equity value
▪ Cerner is a leading provider of digital information systems used
within hospitals and health systems to enable medical
professionals to deliver better healthcare to individual patients
and communities
GSK acquisition of
BELLUS Health
Acquisition $2 Bn April 2023
▪ GSK has acquire BELLUS for US$14.75 per share of common
stock in cash representing an approximate total equity value of
US$2.0 billion
▪ BELLUS is a late-stage biopharmaceutical company working to
better the lives of patients suffering from persistent cough
▪ Acquisition further strengthens specialty medicines and
respiratory pipeline with camlipixant, a highly selective P2X3
antagonist and potential best-in-class treatment for refractory
chronic cough
Latest Deals In UK
Illustrative
25. 25
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
1.9 Mergers and Acquisitions(continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger March 2023
Merger Jan 2023
Latest Deals In UK
Illustrative
27. 27
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
2.1 Market Size and Forecasts (Excel and Methodology)
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
UK Coronary Stents Market Market Forecast, 2022-2030 (in $Bn)
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In this section you will get an
understanding of the overall Healthcare
Insurance market in UK, which includes
the market size, current trends and
other details related to the topic
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
UK Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
UK Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative
28. 28
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
2.2 Snapshot of Coronary Stents Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the UK Coronary Stents Market Analysis
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable
Stents
Mode of Delivery
Balloon-expandable
Stents
Self-expanding
Stents
Materials
Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
End-User
Hospitals
Cardiac Centers
Ambulatory Surgical
Centers
29. 29
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
UK Coronary Stents Market Share, By Type (2022)
Bare Metal
Stents,
Drug Eluting
Stents,
Bioabsorbable
Stents,
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
2.2.1 Market Segmentation: By Type
Illustrative
30. 30
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
UK Coronary Stents Market Share, By Mode of Delivery (2022)
Balloon-
expandable
Stents,
Self-expanding
Stents,
2.2.2 Market Segmentation: By Mode of Delivery
▪ Balloon expandable stents in UK is a
significant component of the overall
coronary stents market
▪ It has the maximum market share in UK
cancer market with approximately 62%
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
31. 31
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
UK Coronary Stents Market Share, By Materials (2022)
2.2.2 Market Segmentation: By Materials
▪ Metallic stents in UK is a significant
component of the overall coronary
stents market
▪ It has the maximum market share in UK
cancer market with approximately xx%
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
Metallic Stents
Cobalt-
Chromium
Platinum
Chromium
Nickel Titanium
Stainless Steel
32. 32
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
UK Coronary Stents Market Share, By End User (2022)
Hospitals
Cardiac Centers
Ambulatory
Surgical Centers
2.2.3 Market Segmentation: By End User
▪ Hospitals have the maximum market
share in UK coronary stents market
with approximately xx%
▪ Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
▪ In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
34. 34
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
3.1 Market growth drivers
▪ Advances in coronary stent technology have contributed to market
growth and have reduced the risk of restenosis
▪ This is driving the demand for coronary stents and creating opportunities
for growth in the coronary stents market
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
3.1.1 Development of drug-eluting stents (DES) with improved drug coatings and innovative designs has helped
enhance the efficacy of stent placement
Illustrative
Incidence of Coronary Artery Disease in
UK
35. 35
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
3.1 Market growth drivers (continued)
Top countries that are leveraging
technology in their fight against cancer
United States
Japan
Germany
South Korea
China
United Kingdom
France
Canada
Australia
Israel
Switzerland
Singapore
Sweden
Netherlands
Italy
Spain
Belgium
Denmark
Austria
Norway
3.1.2 Death rate from cancer in UK has declined by 31% from 1992 to 2022, largely due to advances in technology
and treatment options
▪ UK has a long history of investing in cancer research and
treatment, and as a result, has become a world leader in the
field
▪ IT has a robust healthcare infrastructure, including world-
renowned research institutions, hospitals, and clinics, that
are dedicated to cancer treatment and research
▪ One of the key factors that has allowed UK to stay ahead in
the field of cancer research and treatment is the high level of
investment in cancer-related research
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
36. 36
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
3.1 Market growth drivers (continued)
Fundings from government and other
organizations
3.1.3 In 2021, the National Cancer Institute (NCI) received $6.4 Bn in funding from UK federal government to support
cancer research and training programs
▪ UK government provides significant support and funding for
cancer research and treatment, which is driving innovation
and growth in the cancer market
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Source Year Fund ($)
National Cancer
Institute (NCI)
2021 $ 6.4 Bn
Centers for Disease
Control and
Prevention (CDC)
2021 $ 501 Mn
American Cancer
Society (ACS)
2020 $ 150 Mn
Susan G. Komen 2020 $ 98 Mn
Illustrative
37. 37
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
3.2 Market restraints
3.2.1 In 2020, the
average cost of a new
cancer drug was over
$150,000 per year
▪ Cancer treatments can be very
expensive and can lead to
financial burden for patients and
healthcare systems
▪ Cost of cancer treatment varies
depending on the type of cancer,
stage of cancer, and treatment
options
▪ Some common cancer
treatments, such as
chemotherapy and radiation
therapy, can cost tens of
thousands of dollars
3.2.2 Average cost of
developing a new cancer
drug that is ultimately
approved by the FDA is over
$2.6 Bn
▪ Regulatory requirements for
cancer treatments can be very
stringent, which can slow down
the approval process and limit
access to new treatments
▪ Regulatory bodies, such as UK
Food and Drug Administration
(FDA), require extensive clinical
trials and safety data before
approving new cancer
treatments
▪ This can be a lengthy and costly
process, which can delay the
availability of new treatments for
patients
3.2.3 Demand for cancer care is
expected to increase by 42% by
2025, while the supply of
oncologists is only expected to
increase by 28%
▪ There is a shortage of
oncologists in UK, which can
limit access to cancer treatments
and create barriers to growth in
the cancer market
▪ Oncologists are physicians who
specialize in the diagnosis and
treatment of cancer
▪ With the aging population and
the increasing incidence of
cancer, there is a growing
demand for oncologists
▪ However, the supply of
oncologists is not keeping pace
with the demand
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
39. 39
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.1 Major Market Share
XX
Other
▪ UK coronary stents market is a highly
competitive space, with many companies
developing and marketing cancer
treatments
▪ Some of the top companies in UK coronary
stents market based on revenue and
market share include
▪ Roche is a Swiss multinational healthcare
company that develops and markets
cancer treatments, including targeted
therapies and immunotherapies
▪ In 2020, Roche's oncology sales were
approximately $24 Bn, making it one of the
largest players in UK cancer market
Revenue of Major players in UK Coronary Stents
Market ($ Mn)
Illustrative
40. 40
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2 Key Company Profile
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
1 Abbott Laboratories
3 Medtronic
5 Terumo Corporation
7 C. R. Bard
9
MicroPort Scientific
Corporation
2
Boston Scientific
Corporation
4 Johnson & Johnson
6 B. Braun Melsungen
8 Cook Medical
Biosensors International
Group
10
Key Note:
41. 41
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.1 Abbott Laboratories
Founded in: 1888
HQ: Illinois, US
Type: Private
Revenue: $43.7 Bn
Website: www.abbott.com/
▪ Roche is a pharmaceutical company that develops and produces various
medications, including those used to treat cancer
▪ It has a significant presence in the cancer treatment field in the US
▪ Roche is also involved in clinical trials to develop new cancer treatments
▪ Their clinical pipeline includes drugs for the treatment of various types of
cancer, such as lung cancer, breast cancer, and multiple myeloma
Market Leader in
➢ Glucose Monitoring
➢ Blood And Plasma Screening
➢ Heart Pumps (LVADs)
➢ Remote Heart Failure Monitoring
➢ Point Of Care Testing
Recent Activity / Press Coverage
Abbott completes acquisition of cardiovascular systems, inc.
Abbott's life support system receives new FDA clearances to help doctors treat more critically ill patients
Abbott receives FDA approval for Epic™ max tissue valve to treat aortic valve disease
42. 42
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.1 Abbott Laboratories (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
One of the largest pharmaceutical
distributors in the United States, McKesson
has been a long-standing distribution
partner for Roche
Cardinal Health is a Fortune 500 healthcare
services company that provides
pharmaceutical distribution services to
Roche
It is one of the largest drugstore chains in
the United States and Europe, and its
extensive network of retail locations and
distribution centers make it an important
distribution partner for Roche
A leading healthcare services provider in
Asia, Zuellig Pharma is a distribution
partner for Roche in several Asian countries
One of the largest pharmaceutical
wholesalers in Europe, PHOENIX Group
distributes Roche's products in several
European countries
Roche has been working with SAP, a
leading software company, to develop digital
solutions for its healthcare products
A leading Swiss biotechnology company,
Lonza provides Roche with contract
manufacturing services for the production of
its biologics and pharmaceuticals
Roche has a strategic partnership with
Microsoft to leverage its cloud computing
and AI technologies in the development of
new healthcare products
Thermo Fisher Scientific is a leading
provider of analytical instruments, reagents,
and laboratory services
GE Healthcare provides Roche with
advanced medical imaging and diagnostics
technologies, including CT scanners and
MRI machines
Illustrative
43. 43
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.1 Abbott Laboratories (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Cardiovascular
Systems, Inc
Acquisition - April,2023
▪ Cardiovascular Systems, Inc. (CSI), a manufacturer of medical
devices featuring a cutting-edge atherectomy system used to
treat coronary and peripheral artery disease, has been acquired
by Abbott
▪ Abbott now has a complementary method of treating vascular
disease as a result of the deal. In order to reestablish blood flow,
arteries are prepared for angioplasty or stenting using CSI's top
atherectomy technology
GenMark Diagnostics
Merger $1.8 Bn March 2021
▪ Roche to acquire GenMark Diagnostics for US$ 24.05 per share
with the expectation to close in the 2nd quarter of 2021
▪ GenMark provides molecular diagnostic tests that are designed to
detect multiple pathogens from a single patient sample
▪ GenMark’s ePlex platform delivers rapid and actionable results so
clinicians can determine the cause of infection and the most
effective treatment, potentially saving lives and alleviating the
healthcare burden
Latest Deals - Mergers and Acquisitions
Illustrative
44. 44
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 Abbott Laboratories (continued)
Revenues ($Bn), 2020-2030
▪ According to Roche's 2020 financial report,
the company had sales of CHF 58.3 Bn
(Swiss Francs) in 2020
▪ This is equivalent to approximately $63.3
Bn USD, based on exchange rates at the
end of 2020
▪ Company's Pharmaceuticals Division
generated sales of CHF 49.9 Bn in 2020,
while the Diagnostics Division generated
sales of CHF 8.4 Bn
▪ Revenue generated by Roche in 2020
reflects the company's continued growth
and success in the healthcare industry
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative
45. 45
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative
46. 46
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative
47. 47
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
4.2.2 Company 2 (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative
48. 48
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative
50. 50
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
5.1 Reimbursement Regulation
The reimbursement scenario in the US cancer market is complex and can vary
depending on the specific treatment, setting of care, and insurance coverage.
Here are some key points to consider:
▪ Medicare:
o Medicare is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Medicare covers many cancer treatments, including chemotherapy,
radiation therapy, and some immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
▪ Medicaid:
o Medicaid is a joint federal-state program that provides health insurance
for people with low incomes
o Medicaid coverage for cancer treatments can vary by state, and may be
subject to limits on the amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Americans
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative
51. 51
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
5.1 Reimbursement Regulation (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover
certain preventive services, including cancer screenings, without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as cancer
▪ Reimbursement for New Treatments:
o Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs
often require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
52. 52
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
53. 53
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
5.2 Reimbursement Process for Diagnosis of Heart Disease
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
54. 54
A Sample Report on UK Coronary Stents Market Analysis Analysis I Confidential
5.3 Reimbursement Process for Treatment of Heart Disease
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative
56. Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
57. Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research
58. Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary
59. Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
60. 2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period
62. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust
63. www.insights10.com
A large database of over 30,000 syndicated
market research reports in Medical Devices and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions
64. Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com
65. Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com
71. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
72. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
73. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
74. What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read
76. “The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO
77. Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager